9 completed, 1 unknown, 1 withdrawn. 11 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 9, Unknown 1, Withdrawn 1 |
Follow amprenavir: new trials by email Literature Review of amprenavir trials Research Report on amprenavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers Indinavir sulfate, Ritonavir, Amprenavir - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 90 | 2001-03-01 | 2021-11-01 |
| Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV Tetanus Toxoid Vaccine, Indinavir sulfate, Lamivudine/Zidovudine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 288 | 1999-10-01 | 2011-03-02 |
| Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication Ritonavir, Abacavir sulfate, Amprenavir - HIV Infections | Not applicable | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-09 | ||
| An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen Abacavir sulfate, Amprenavir - HIV Infections | Not applicable | Completed | Glaxo Wellcome | 2005-06-24 | ||
| Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment Ritonavir, Amprenavir - HIV Infections | Not applicable | Unknown | Gathe, Joseph, M.D. | 2005-06-24 | ||
| A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications Amprenavir - HIV Infections | Not applicable | Completed | Glaxo Wellcome | 2005-06-24 | ||
| A Study of Amprenavir in HIV-Infected Patients Amprenavir - HIV Infections | Not applicable | Completed | Glaxo Wellcome | 2005-06-24 | ||
| A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection Indinavir sulfate, Lamivudine/Zidovudine, Ritonavir - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 900 | 2012-06-07 | |
| A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs Lamivudine/Zidovudine, Abacavir sulfate, Amprenavir - HIV Infections | Not applicable | Completed | Glaxo Wellcome | 2005-06-24 | ||
| A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment Lamivudine/Zidovudine, Abacavir sulfate, Amprenavir - HIV Infections | Not applicable | Completed | Glaxo Wellcome | 2005-06-24 | ||
| Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients Abacavir sulfate, Amprenavir, Lamivudine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2015-05-15 |
HIV Infections (11) · Hepatitis B (1) · Hyperlipidemias (1) · Lipodystrophy (1) · Patient Compliance (1) · Tetanus (1)
Glaxo Wellcome (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Gathe, Joseph, M.D. (1)
United States (11) · Australia (1) · Italy (1) · Puerto Rico (1)
Cara Wilson (1) · Gene Morse (1) · Gregory Robbins (1) · Lawrence Corey (1) · Martin Markowitz (1) · Robert Shafer (1)
PMID 14668455, PMID 14668456, PMID 15187476, PMID 16048950, PMID 16048984, PMID 16103764, PMID 16267764, PMID 16810109, PMID 16816555, PMID 17662759, PMID 20467286, PMID 24326304, PMID 33901188